Printer Friendly

BIODYNAMICS COMPLETES GERMAN ACQUISITION

 NUREMBERG, Germany, May 5 /PRNewswire/ -- Biodynamics International, Inc. (NASDAQ: BDYN) announced today that its recently formed subsidiary, Biodynamics International (Deutschland), GmbH, ("BID") has completed the acquisition of the Wound Care Division of Pfrimmer-Viggo GmbH & Co. KG ("Wound Care"). The purchase price is approximately DM 22.00 million or approximately $13.96 million and is subject to certain post closing adjustments.
 The company raised a total of $16.34 million to finance the acquisition and provide initial working capital, $12.34 million of which was in the form of senior secured, mezzanine and investor loans made directly to BID from six European sources. The balance of $4 million was raised through the U.S. company's placement of convertible debentures to two U.S. investment companies.
 The senior secured debt was provided by Bayerische Vereinsbank, Erlangen, Germany, in the form of a 15-year mortgage on the acquired property and plant in the amount $1.97 million.
 A total of $4.44 million of mezzanine debt came from National Westminster Bank plc and Kleinwort Benson European Mezzanine Fund, B.V. and is repayable in two equal installments in 1998 and 1999. The mezzanine lenders received a five-year warrant to purchase 35,000 common shares of the company at a price of $3.325 per share.
 Investor loans totaling $5.93 million were made to BID by Alta- Berkeley III C.V., Charterhouse Second Venture Fund Management Limited and Kleinwort Benson European Mezzanine Fund L.P. These loans are repayable in full at maturity in March 2003 or can be converted to shares of common stock of the company at either a price of $3.50 per share or, based on a valuation of BID at time of conversion. Interest on these loans, although accrued, may only be paid beginning in 1996 provided that the cash flow of BID exceeds minimums as set forth by the mezzanine lenders. The investors will receive a five-year warrant to purchase 100,000 shares at a price of $3.325 per share.
 Seven-year 11 percent debentures convertible to common shares of the company at a per-share price of $3.50 totaling $4 million were purchased by Renaissance Capital Partners II, Ltd., Dallas, and OREFUND, Beverly Hills, Calif. The debentures call for $2 million to be repaid over a four-year period beginning in the fourth year with the remaining $2 million due at maturity.
 Wound Care revenues totaled approximately $10.97 million for fiscal 1992 and were primarily derived from processing tissue allografts for a variety of surgical applications. Wound Care also manufactures an extensive line of surgical sutures. John V. Hargiss, president, stated, "Wound Care, or Biodynamics International (Deutschland) as it will now be called, brings to our company an abundance of resources; a proven technology, an established global market presence and most of all, experienced, talented people. These newly acquired resources combined with our rapidly growing U.S. distribution network will provide an excellent base for continued market penetration and expansion."
 Biodynamics International, Inc. processes, manufactures and distributes worldwide, specialty surgical products for neuro, orthopedic, cardiovascular, reconstructive and general surgical applications. The company is a Florida corporation with executive offices in Tampa, Fla. and processing and manufacturing facilities in Neunkirchen, Germany.
 -0- 5/5/93
 /CONTACT: John V. Hargiss or Charles C. Dragone of Biodynamics International, 813-979-0016/
 (BDYN)


CO: Biodynamics International, Inc.; Pfrimmer-Viggo GmbH & Co. KG ST: Florida IN: HEA SU: TNM

AW-JB -- FL012 -- 4955 05/05/93 14:46 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 5, 1993
Words:574
Previous Article:COLUMBIA PICTURES TELEVISION DISTRIBUTION CREATES NEW MEDIA MARKETING COMPANY FOR ADVERTISER SALES
Next Article:FIRST-QUARTER HOME SALES RISE IN 29 STATES, NAR REPORTS
Topics:


Related Articles
AMERICAN BIODYNAMICS ANNOUNCES PRIVATE PLACEMENT OF $800,000 IN RESTRICTED COMMON STOCK
AMERICAN BIODYNAMICS SHAREHOLDERS APPROVE MOVE OF COMPANY AND NAME CHANGE
BIODYNAMICS REPORTS RECORD NINE MONTH REVENUES AND PROFIT
BIODYNAMICS TO COMPLETE PURCHASE OF BUSINESS AT END OF YEAR
BIODYNAMICS REPORTS SHARP INCREASE IN YEAR END RESULTS
BIODYNAMICS PREPARED TO CLOSE ON ACQUISITION
BIODYNAMICS NAMES SENIOR MANAGEMENT TEAM FOR NEW GERMAN ACQUISITION
BIODYNAMICS REPORTS MID-YEAR RESULTS
BIODYNAMICS REPORTS RESULTS FOR SHORTENED FISCAL YEAR
BIODYNAMICS INTERNATIONAL MAKES ANNOUNCEMENT

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters